{"nct_id":"NCT02131233","title":"Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)","status":"COMPLETED","status_verified_date":"2019-01","start_date":"2014-05-23","start_date_type":"ACTUAL","primary_completion_date":"2015-12-21","primary_completion_date_type":"ACTUAL","completion_date":"2016-12-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["MRK"]}